Stopped: Enrollment suspended pending protocol revision to change study to observational
The purpose of this study is to determine whether Campath-1H induction and the associated lymphocyte depletion will permit long-term rejection-free renal allograft survival in the absence of ongoing corticosteroid administration.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Incidence of Graft Rejection
Timeframe: at 1, 3, 6, 12, and 24 months
Participant Graft Survival
Timeframe: at 6, 12, and 24 months